Tenax Therapeutics, Inc.

TENXNASDAQHealthcareBiotechnology

$1.36- (-)1Y −77.41%

As of Oct 16, 2026 close

Market cap: $76.81M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $1.31$19.40
Volume (live): -
Avg. volume (3M): 3.10M

Tenax Therapeutics, Inc. (TENX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Tenax Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy

Based on 11 unique analysts

(13 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$9.63

+608.09% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest TENX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 9, 2026	David Risinger	Leerink Partners	Maintains	Buy	$4.00
Sep 15, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$14.00
Sep 10, 2026	Olivia Brayer	Cantor Fitzgerald	Maintains	Buy	$35.00
Sep 1, 2026	Angela Qian	Canaccord Genuity	Maintains	Buy	$4.00
Aug 31, 2026	Angela Qian	Canaccord Genuity	Maintains	Buy	$4.00
Aug 31, 2026	Seamus Fernandez	Guggenheim	Downgrades	Hold	-
Aug 31, 2026	Matt Phipps	William Blair	Maintains	Hold	-
Aug 11, 2026	Gautam Chukka	Chardan Capital	Downgrades	Hold	$27.00 → $5.00 −22.00 (−81.5%)
Aug 11, 2026	David Risinger	Leerink Partners	Maintains	Buy	$26.00 → $4.00 −22.00 (−84.6%)
Aug 10, 2026	Gaurav Maini	LifeSci Capital	Maintains	Buy	$35.00 → $5.00 −30.00 (−85.7%)
Aug 10, 2026	Jonathan Aschoff	Roth MKM	Maintains	Buy	$30.00 → $5.00 −25.00 (−83.3%)
Aug 10, 2026	Gavin Clark-Gartner	Evercore ISI Group	Upgrades	Hold	$39.00 → $5.00 −34.00 (−87.2%)
Jul 21, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-

David Risinger

Leerink Partners

BuyMaintains

$4.00

Oct 9

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$14.00

Sep 15

Olivia Brayer

Cantor Fitzgerald

BuyMaintains

$35.00

Sep 10

Angela Qian

Canaccord Genuity

BuyMaintains

$4.00

Sep 1

Angela Qian

Canaccord Genuity

BuyMaintains

$4.00

Aug 31

Seamus Fernandez

Guggenheim

HoldDowngrades

Aug 31

Matt Phipps

William Blair

HoldMaintains

Aug 31

Gautam Chukka

Chardan Capital

HoldDowngrades

$27.00 → $5.00

Aug 11

David Risinger

Leerink Partners

BuyMaintains

$26.00 → $4.00

Aug 11

Gaurav Maini

LifeSci Capital

BuyMaintains

$35.00 → $5.00

Aug 10

Jonathan Aschoff

Roth MKM

BuyMaintains

$30.00 → $5.00

Aug 10

Gavin Clark-Gartner

Evercore ISI Group

HoldUpgrades

$39.00 → $5.00

Aug 10

Zacks Equity Research

BuyInitiates Coverage

Jul 21

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for TENX?

The analyst consensus rating for TENX is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for TENX?

The average 12-month price target for TENX is $9.63, representing an upside of 608.1% from the Oct 16, 2026 close of $1.36.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.